EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparing Gallyas and AT8 staining for quantification of tau pathology in subregions of the human hippocampus

Bayla Breningstall iD, Evan Abdollahi, Debra Hawes, Annie Hiniker, Michael S Bienkowski iD

Journal of Neuropathology & Experimental Neurology · 2026

DOI: 10.1093/jnen/nlaf149 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2026. Verfasst von Bayla Breningstall und 4 weiteren Autor:innen. Beteiligte Einrichtung: Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, United States. Hauptthemen laut MEDLINE: tau Proteins, Hippocampus, Alzheimer Disease, Staining and Labeling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Disease Research Center Neuropathology Core, University of Southern California Center for Neuronal Longevity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gallyas silver staining and AT8 immunostaining are frequently used to stage tau pathology in post-mortem Alzheimer disease (AD) brains. Because of differential labeling of tau aggregation types, however, these methods result in strikingly different patterns of pathology when used in adjacent sections of the same brain. How Gallyas versus AT8 staining impacts the quantification of tau pathology distribution across brain areas and affect analysis of tau and cognitive impairment is unknown. We performed a side-by-side comparison of AT8 versus Gallyas-stained hippocampal sections from 34 patients from the University of Southern California (USC) Alzheimer’s Disease Research Center (ADRC). Using images of Gallyas and AT8 stained sections, we computed overall tau density in hippocampal subregions as well as manual tangle counts and compared each of them to cognitive variables like Clinical Dementia Rating and Mini Mental State Exam in the patients. We found that AT8 had a much higher density of staining overall, and the two stains had differing distributions, with increased AT8 in Brodmann area 35 and CA1. Both stains related to cognition differentially, and Gallyas density was significantly related to post-mortem interval. These findings contribute to our understanding of how tau pathology stain choice might influence the characterization of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsHippocampusAlzheimer DiseaseStaining and LabelingSilver StainingHumansFemaleAgedMaleAged, 80 and overNeurofibrillary Tangles

Stichwörter der Autor:innen

Alzheimer diseasecomputational neuroanatomydigital pathologyhippocampushumantau neuropathologywhole slide images

Substanzen

tau ProteinsMAPT protein, human

Autor:innen und Institutionen

  • Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, United States.
  • USC Center for Integrative Connectomics, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, United States.
  • Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, United States.
  • Department of Pathology, University of Southern California, Keck School of Medicine of USC, Los Angeles, CA, United States.
  • Zilkha Neurogenetic Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, United States.
  • Department of Physiology and Neuroscience, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, United States.

ORCID-Profile: Bayla Breningstall, Michael S Bienkowski

Förderung

  • NIA NIH HHS
  • Alzheimer's Disease Research Center Neuropathology Core
  • University of Southern California Center for Neuronal Longevity
  • Epstein Family Foundation Alzheimer's Research Collaboration Gene Therapy Program (MSB, A.H.) and the University of Southern California Center for Neuronal Lon…
  • Epstein Family Foundation Alzheimer's Research Collaboration Gene Therapy Program
  • National Institute on Aging
  • Epstein Family Foundation Alzheimer’s Research Collaboration Gene Therapy Program
  • Alzheimer’s Disease Research Center Neuropathology Core

Zitieren

APA

Breningstall, B., Abdollahi, E., Hawes, D., Hiniker, A., & Bienkowski, M. S. (2026). Comparing Gallyas and AT8 staining for quantification of tau pathology in subregions of the human hippocampus. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlaf149

Vancouver

Breningstall B, Abdollahi E, Hawes D, Hiniker A, Bienkowski MS. Comparing Gallyas and AT8 staining for quantification of tau pathology in subregions of the human hippocampus. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlaf149

BibTeX
@article{Breningstall2026,
  author = {Breningstall, Bayla and Abdollahi, Evan and Hawes, Debra and Hiniker, Annie and Bienkowski, Michael S},
  title = {Comparing Gallyas and AT8 staining for quantification of tau pathology in subregions of the human hippocampus},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2026},
  doi = {10.1093/jnen/nlaf149}
}
Kostenlos starten →